BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,067 filers reported holding BAXTER INTL INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,614,748 | -29.4% | 2,003,856 | -14.7% | 0.12% | -23.7% |
| Q2 2023 | $107,078,665 | +22.8% | 2,350,278 | +9.3% | 0.16% | +13.9% |
| Q1 2023 | $87,227,355 | +71.8% | 2,150,576 | +115.9% | 0.14% | +59.3% |
| Q4 2022 | $50,776,019 | -28.6% | 996,194 | -24.5% | 0.09% | -28.3% |
| Q3 2022 | $71,075,000 | +59.9% | 1,319,608 | +94.3% | 0.12% | +69.0% |
| Q2 2022 | $44,441,000 | -28.7% | 679,135 | -15.5% | 0.07% | -14.5% |
| Q1 2022 | $62,348,000 | +53.9% | 804,067 | +60.3% | 0.08% | +66.0% |
| Q4 2021 | $40,519,000 | -30.3% | 501,617 | -28.5% | 0.05% | -38.3% |
| Q3 2021 | $58,103,000 | +40.1% | 702,008 | +36.3% | 0.08% | +42.1% |
| Q2 2021 | $41,475,000 | +7.2% | 515,211 | +12.3% | 0.06% | -1.7% |
| Q1 2021 | $38,688,000 | +22.8% | 458,712 | +16.8% | 0.06% | +9.4% |
| Q4 2020 | $31,513,000 | -32.9% | 392,744 | -32.7% | 0.05% | -39.1% |
| Q3 2020 | $46,962,000 | -60.6% | 583,960 | -57.8% | 0.09% | -61.7% |
| Q2 2020 | $119,051,000 | +33.3% | 1,382,709 | +25.7% | 0.23% | +15.8% |
| Q1 2020 | $89,282,000 | -29.0% | 1,099,660 | -26.9% | 0.20% | +5.9% |
| Q4 2019 | $125,721,000 | -11.2% | 1,503,484 | -7.1% | 0.18% | -17.0% |
| Q3 2019 | $141,549,000 | +2.5% | 1,618,263 | -4.0% | 0.22% | +4.2% |
| Q2 2019 | $138,083,000 | +83.7% | 1,685,993 | +82.4% | 0.21% | +71.2% |
| Q1 2019 | $75,163,000 | -14.2% | 924,395 | -30.5% | 0.12% | -18.8% |
| Q4 2018 | $87,592,000 | -33.8% | 1,330,791 | -22.5% | 0.15% | -21.0% |
| Q3 2018 | $132,374,000 | +57.9% | 1,717,135 | +51.2% | 0.20% | +56.0% |
| Q2 2018 | $83,845,000 | -38.0% | 1,135,511 | -45.4% | 0.12% | -39.3% |
| Q1 2018 | $135,191,000 | -36.8% | 2,078,571 | -37.2% | 0.21% | -29.2% |
| Q4 2017 | $213,783,000 | +6.2% | 3,307,293 | +3.1% | 0.29% | +0.7% |
| Q3 2017 | $201,370,000 | +3.1% | 3,209,083 | -0.5% | 0.29% | -0.7% |
| Q2 2017 | $195,318,000 | +36.5% | 3,226,264 | +16.9% | 0.29% | +30.5% |
| Q1 2017 | $143,096,000 | +23.3% | 2,759,284 | +5.4% | 0.22% | +19.3% |
| Q4 2016 | $116,076,000 | +13.8% | 2,617,872 | +22.2% | 0.19% | +11.3% |
| Q3 2016 | $101,956,000 | +173.8% | 2,141,942 | +160.1% | 0.17% | +166.7% |
| Q2 2016 | $37,236,000 | -72.1% | 823,448 | -74.6% | 0.06% | -73.6% |
| Q1 2016 | $133,417,000 | +256.9% | 3,247,756 | +231.5% | 0.24% | +251.5% |
| Q4 2015 | $37,381,000 | +42.7% | 979,846 | +22.9% | 0.07% | +30.8% |
| Q3 2015 | $26,190,000 | -55.3% | 797,276 | -4.9% | 0.05% | -50.0% |
| Q2 2015 | $58,600,000 | -10.2% | 837,976 | -12.1% | 0.10% | -8.0% |
| Q1 2015 | $65,272,000 | -12.9% | 952,876 | -6.8% | 0.11% | -16.9% |
| Q4 2014 | $74,900,000 | -1.6% | 1,021,976 | -3.6% | 0.14% | -4.9% |
| Q3 2014 | $76,118,000 | +7.4% | 1,060,576 | +8.1% | 0.14% | +14.4% |
| Q2 2014 | $70,902,000 | -36.9% | 980,666 | -35.7% | 0.12% | -40.2% |
| Q1 2014 | $112,289,000 | +51.6% | 1,526,076 | +43.3% | 0.21% | +42.2% |
| Q4 2013 | $74,069,000 | -19.3% | 1,064,976 | -23.8% | 0.15% | -24.6% |
| Q3 2013 | $91,791,000 | +17.3% | 1,397,336 | +23.7% | 0.20% | +12.7% |
| Q2 2013 | $78,254,000 | – | 1,129,706 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |